Globus Medical To Merge With NuVasive In $3.1Bn All-Stock Deal Analysts Foresee Challenges

Analysts from Piper Sandler and BTIG noted that the proposed merger between Globus Medical and NuVasive raises concerns about cultural fit, approach to commercialization and profitability, as well as anti-trust issues.